Patents by Inventor Karin Mittmann

Karin Mittmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fluorescent nanoparticles
    Patent number: 8974767
    Abstract: The use of fluorescent nanoparticles is disclosed which includes an inorganic core, a passivating layer and specific ligands having a hydrodynamic diameter of the inorganic core with the passivating layer of not more than 15 nm, preferably of not more than 10 nm, particularly preferably of not more than 5 nm, for preparing an in vivo diagnostic aid, the nanoparticles showing an emission of less than 700 nm.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: March 10, 2015
    Assignee: Signalomics GmbH
    Inventors: Sven Laarmann, Kathrin Zeller, Karin Mittmann, Christoph Block, Claudia Arntz
  • Optimized adhesin fragments and corresponding nanoparticles
    Patent number: 8796200
    Abstract: The invention relates to optimized adhesins and nanoparticles to which said adhesins are bound. The invention furthermore relates to providing said nanoparticles by way of in vivo contrast agents, in particular for the diagnosis of bowel cancer.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: August 5, 2014
    Assignee: Signalomics GmbH
    Inventors: Christoph Block, Karin Mittmann, Claudia Arntz
  • Optimized Adhesin Fragments And Corresponding Nanoparticles
    Publication number: 20110110856
    Abstract: The invention relates to optimized adhesins and nanoparticles to which said adhesins are bound. The invention furthermore relates to providing said nanoparticles by way of in vivo contrast agents, in particular for the diagnosis of bowel cancer.
    Type: Application
    Filed: June 17, 2008
    Publication date: May 12, 2011
    Applicant: Signalomics GmbH
    Inventors: Christoph Block, Karin Mittmann, Claudia Arntz
  • RNA-HELICASE AS A MARKER FOR RARE TUMORS
    Publication number: 20090239935
    Abstract: Method for the diagnosis of diseases in a mammal, preferably in a human, wherein a probe from the mammal is examined with a view to an elevated level of RNA helicase and the elevated level of RNA helicase indicates the disease. The disease refers to esophagus carcinoma, pancreas carcinoma, stomach carcinoma, hepatocellular carcinoma, hepatoblastoma and cholangiocellular carcinoma.
    Type: Application
    Filed: December 14, 2006
    Publication date: September 24, 2009
    Applicants: Signalomics GMBH, Mayo Foundation for Medical Education and Research
    Inventors: Kathrin Zeller, Sven Laarmann, Karin Mittmann, Christoph Block, Ralf Janknecht
  • FLUORESCENT NANOPARTICLES
    Publication number: 20090226371
    Abstract: The use of fluorescent nanoparticles comprising an inorganic core, a passivating layer and specific ligands having a hydrodynamic diameter of the inorganic core with the passivating layer of not more than 15 nm, preferably of not more than 10 nm, particularly preferably of not more than 5 nm, for preparing an in vivo diagnostic aid, the nanoparticles showing an emission of less than 700 nm.
    Type: Application
    Filed: November 16, 2006
    Publication date: September 10, 2009
    Applicant: Signalomics GmbH
    Inventors: Sven Laarmann, Kathrin Zeller, Karin Mittmann, Christoph Block, Claudia Arntz